Studies on camptothecin solid lipid nanoparticles

Yaoxue Xuebao

Volumn 34, Issue 2, 1999, Pages 146-150

  Yang, Shicheng ^a   Zhu, Jiabi ^b   Liang, Bingwen ^c   Yang, Changzheng ^a  

^a NANJING UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c The 81st Hospital of PLA   (China)

Author keywords

Camptothecin; Solid lipid nanoparticles; Targeting

Indexed keywords

EID: 0042377676     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wall ME, Wani MC, Cook CE, et al. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc, 1966, 88: 3888
2. Jaxel C, Kohn KW, Wani MC, et al. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. Cancer Res, 1989, 49:1465
3. Fassberg J, Stella VJ. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogs. J Pharm Sci, 1992, 81:676
4. Potmesil M. Camptothecin: from bench research to hospital words. Cancer Res, 1994, 54:1431
5. Müller RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm, 1995, 41:62
6. Müller RH, Maassen S, Schwarz C, et al. Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes. J Control Release, 1997, 47:261
7. Müller RH, Rühl D, Runge S, et al. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res, 1997, 14:458
8. Moghimi SM. Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block co-polymers. Adv Drug Delivery Rev, 1995, 16:183
9. Lenaerts V, Labib A, Chouinard F, et al. Nanocapsules with a reduced liver uptake: targeting of phthalocyanines to EMT-6 mouse mammary tumour in vivo. Eur J Pharm Biopharm, 1995, 41:38
10. Boltril L, Canal T, Esposito P, et al. Relevant factors affecting the formation and growth of lipid nanospheres suspensions. Eur J Pharm Biopharm, 1995, 41:70
11. Siekmann B, Westesen K. Investigations on solid lipid nanoparticles prepared by precipitation in O/W emulsions. Eur J Pharm Biopharm, 1996, 43:104
12. Lon JP, Ahmed AE. Determination of camptothecin in biological fluids using reversed phase high performance liquid chromatography with fluorescence detection. J Chromatogr B. Biomed Appl, 1990, 530:367
13. Mi Z, Burke TG. Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study. Biochemistry, 1994, 33:12540